View Financial HealthDhariwal 配当と自社株買い配当金 基準チェック /06Dhariwal配当金を支払った記録がありません。主要情報n/a配当利回り0%バイバック利回り総株主利回り0%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Mar 23New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (31% accrual ratio). Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹4.05b market cap, or US$43.3m).お知らせ • Mar 23Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million.Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 47,007,000 Price\Range: INR 2.5 Transaction Features: Rights OfferingValuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 43%After last week's 43% share price decline to ₹41.80, the stock trades at a trailing P/E ratio of 47.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 97% over the past year.分析記事 • Nov 14Dhariwal Corp Limited (NSE:DHARIWAL) Stock Rockets 64% As Investors Are Less Pessimistic Than ExpectedDespite an already strong run, Dhariwal Corp Limited ( NSE:DHARIWAL ) shares have been powering on, with a gain of 64...お知らせ • Nov 14Dhariwal Corp Limited to Report First Half, 2026 Results on Nov 14, 2025Dhariwal Corp Limited announced that they will report first half, 2026 results on Nov 14, 2025分析記事 • Sep 27Optimistic Investors Push Dhariwal Corp Limited (NSE:DHARIWAL) Shares Up 27% But Growth Is LackingDespite an already strong run, Dhariwal Corp Limited ( NSE:DHARIWAL ) shares have been powering on, with a gain of 27...分析記事 • Aug 15Here's Why We Think Dhariwal (NSE:DHARIWAL) Is Well Worth WatchingNSEI:DHARIWAL 1 Year Share Price vs Fair Value Explore Dhariwal's Fair Values from the Community and select yours It's...Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹174, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 29x in the Chemicals industry in India.お知らせ • Jul 14Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025, at 12:30 Indian Standard Time. Location: g-764 boranada industrial area, iv phase, rajasthan - 342012., jodhpur IndiaNew Risk • Jul 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.34b market cap, or US$15.7m).New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.32b market cap, or US$15.4m).Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹142, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 25x in the Chemicals industry in India.New Risk • Mar 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$10.3m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹899.6m market cap, or US$10.3m).Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹91.25, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 25x in the Chemicals industry in India.New Risk • Feb 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.2% average weekly change). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$12.8m).New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹1.24b market cap, or US$14.5m).Reported Earnings • Nov 15First half 2025 earnings releasedFirst half 2025 results: EPS: ₹3.68. Net income: ₹26.8m (up ₹26.8m from 1H 2024).Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹165, the stock trades at a trailing P/E ratio of 32.8x. Average trailing P/E is 35x in the Chemicals industry in India.決済の安定と成長配当データの取得安定した配当: DHARIWALの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: DHARIWALの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Dhariwal 配当利回り対市場DHARIWAL 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (DHARIWAL)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Chemicals)0.8%アナリスト予想 (DHARIWAL) (最長3年)n/a注目すべき配当: DHARIWALは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: DHARIWALは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: DHARIWALの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: DHARIWALが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 23:14終値2026/05/22 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dhariwal Corp Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Mar 23New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 110% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). High level of non-cash earnings (31% accrual ratio). Shareholders have been substantially diluted in the past year (110% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹4.05b market cap, or US$43.3m).
お知らせ • Mar 23Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million.Dhariwal Corp Limited has completed a Follow-on Equity Offering in the amount of INR 117.5175 million. Security Name: Equity Shares Security Type: Common Stock Securities Offered: 47,007,000 Price\Range: INR 2.5 Transaction Features: Rights Offering
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorates as stock falls 43%After last week's 43% share price decline to ₹41.80, the stock trades at a trailing P/E ratio of 47.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 97% over the past year.
分析記事 • Nov 14Dhariwal Corp Limited (NSE:DHARIWAL) Stock Rockets 64% As Investors Are Less Pessimistic Than ExpectedDespite an already strong run, Dhariwal Corp Limited ( NSE:DHARIWAL ) shares have been powering on, with a gain of 64...
お知らせ • Nov 14Dhariwal Corp Limited to Report First Half, 2026 Results on Nov 14, 2025Dhariwal Corp Limited announced that they will report first half, 2026 results on Nov 14, 2025
分析記事 • Sep 27Optimistic Investors Push Dhariwal Corp Limited (NSE:DHARIWAL) Shares Up 27% But Growth Is LackingDespite an already strong run, Dhariwal Corp Limited ( NSE:DHARIWAL ) shares have been powering on, with a gain of 27...
分析記事 • Aug 15Here's Why We Think Dhariwal (NSE:DHARIWAL) Is Well Worth WatchingNSEI:DHARIWAL 1 Year Share Price vs Fair Value Explore Dhariwal's Fair Values from the Community and select yours It's...
Valuation Update With 7 Day Price Move • Jul 25Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹174, the stock trades at a trailing P/E ratio of 37.1x. Average trailing P/E is 29x in the Chemicals industry in India.
お知らせ • Jul 14Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025Dhariwal Corp Limited, Annual General Meeting, Aug 07, 2025, at 12:30 Indian Standard Time. Location: g-764 boranada industrial area, iv phase, rajasthan - 342012., jodhpur India
New Risk • Jul 13New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.34b market cap, or US$15.7m).
New Risk • Jun 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10.0% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Market cap is less than US$100m (₹1.32b market cap, or US$15.4m).
Valuation Update With 7 Day Price Move • May 13Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₹142, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 25x in the Chemicals industry in India.
New Risk • Mar 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹899.6m (US$10.3m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹899.6m market cap, or US$10.3m).
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹91.25, the stock trades at a trailing P/E ratio of 19.4x. Average trailing P/E is 25x in the Chemicals industry in India.
New Risk • Feb 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.2% average weekly change). Minor Risk Market cap is less than US$100m (₹1.11b market cap, or US$12.8m).
New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹1.24b market cap, or US$14.5m).
Reported Earnings • Nov 15First half 2025 earnings releasedFirst half 2025 results: EPS: ₹3.68. Net income: ₹26.8m (up ₹26.8m from 1H 2024).
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹165, the stock trades at a trailing P/E ratio of 32.8x. Average trailing P/E is 35x in the Chemicals industry in India.